Browsing byAuthor김광명

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 22 of 22

Issue DateTitleAuthor(s)Type
2023Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-Therapy김광명Article
2023All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy김광명Article
2023Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy김광명Review
2022Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy김광명Article
2023Enhanced delivery of the phototherapeutic nanoparticles via hepatocyte overload김광명Article
2023Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells김광명Review
2022Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light김광명Article
2023In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy김광명Article
2023In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity김광명Article
2022Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy김광명Review
2023Intracellular Glucose-Depriving Polymer Micelles for Antiglycolytic Cancer Treatment김광명Article
2022Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity김광명Article
2022Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy김광명Article
2023Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy김광명Article
2022Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy김광명Article
2023Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors김진성; 김광명Review
2022Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity김광명Article
2022Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models김광명Article
2024Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy김광명Review
2023Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems김광명Review
2023Thermally Managed, Injectable Optoelectronic Probe with Heat Dissipation Guide for Photodynamic Therapy김광명Article
2022Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy김광명Article

BROWSE